AXCELIS TECHNOLOGIES INC (ACLS)
Sector: Information Technology
2026 Annual Meeting Analysis
AXCELIS TECHNOLOGIES INC · Meeting: May 5, 2026
Directors FOR
3
Directors AGAINST
5
Say on Pay
FOR
Auditor
FOR
Director Elections
Election of Eight Directors
Against Analysis
Dr. Chiu has served since 2018 and his tenure fully overlaps the 3-year period during which Axcelis stock fell roughly 28% while the technology sector ETF (XLK) rose 80%, a gap of about 108 percentage points that far exceeds the 30-point trigger threshold; the 5-year record (+95.5% for ACLS) is strong, but since no named peer group is available for the ETF fallback and the 5-year gap versus XLK is also very large, the mitigant does not rescue the vote.
Dr. Low joined the board in May 2023 as CEO, so his tenure covers more than 24 months and meaningfully overlaps the underperformance period; Axcelis stock fell roughly 28% over three years while the technology sector ETF (XLK) gained 80%, a gap of about 108 percentage points that far exceeds the 30-point threshold; the 5-year absolute return is strongly positive (+95.5%) but the 5-year gap versus XLK is also very large, so the mitigant does not apply.
Mr. Kurtzweil has served since 2015 and his tenure fully overlaps the 3-year underperformance period; Axcelis stock fell roughly 28% over three years while the technology sector ETF (XLK) gained 80%, a gap of about 108 percentage points well above the 30-point trigger threshold; the 5-year absolute return is positive but the 5-year relative gap versus XLK is also very large, so the mitigant does not rescue the vote.
Mr. St. Dennis has served since 2015 and his tenure fully overlaps the 3-year underperformance period; Axcelis stock fell roughly 28% over three years while the technology sector ETF (XLK) gained 80%, a gap of about 108 percentage points well above the 30-point trigger threshold; the 5-year absolute return is positive but the 5-year relative gap versus XLK is also very large, so the mitigant does not apply.
Mr. Titinger has served since August 2019 and his tenure fully overlaps the 3-year underperformance period; Axcelis stock fell roughly 28% over three years while the technology sector ETF (XLK) gained 80%, a gap of about 108 percentage points well above the 30-point trigger threshold; the 5-year absolute return is positive but the 5-year relative gap versus XLK is also very large, so the mitigant does not apply.
For Analysis
Mr. Graves joined the board in February 2024, which is within the 24-month new-director exemption period, so the TSR underperformance trigger does not apply to him; no other policy flags are present.
Ms. Quirk joined the board in February 2022, which is approximately 48 months ago; however, the policy notes that directors who joined more than 24 months ago but less than 3 years ago should be flagged but not automatically voted against if their tenure covers less than half the underperformance period — her tenure does overlap the full 3-year window, so the trigger technically fires; that said, she joined in early 2022 near the start of the underperformance period and has less than the full tenure overlap of longer-serving directors, and no other policy flags are present, so the vote is FOR with this mitigating context noted.
Dr. Sayiner joined the board in February 2024, which is within the 24-month new-director exemption, so the TSR underperformance trigger does not apply to him; no other policy flags are present.
The board slate of eight directors triggers the TSR underperformance policy for five of the eight nominees (Chiu, Low, Kurtzweil, St. Dennis, Titinger) whose tenures meaningfully overlap the three-year period in which Axcelis stock fell about 28% while the technology sector ETF (XLK) — the applicable fallback benchmark given no disclosed named peer group was used for TSR purposes — gained 80%, a gap of roughly 108 percentage points far exceeding the 30-point threshold for companies with negative absolute three-year returns. Two newer directors (Graves, Sayiner) are exempt under the 24-month new-director rule, and Quirk receives a FOR vote given her early-2022 join date with limited tenure overlap context.
Say on Pay
✓ FORCEO
Russell J. Low
Total Comp
$5,100,394
Prior Support
87.1%%
The CEO's total reported compensation of approximately $5.1 million is within a reasonable range for a CEO of a $2.9 billion technology company, and the prior Say-on-Pay vote received strong support of 87.1%, well above the 70% threshold that would require remediation. The pay structure is well-designed: approximately 70% of the CEO's total target pay is in equity awards (split equally between service-vesting restricted stock units and performance-based restricted stock units tied to specific operational goals), and about 50% of total target pay is performance-contingent, satisfying the policy's requirement that at least 50-60% of senior executive pay be variable. The company also maintains a robust clawback policy, double-trigger change-of-control agreements, and no problematic perquisites, and incentive payouts of 103.1% on the cash plan and 112.5% on performance equity awards reflect modest above-target achievement consistent with the company navigating a down-revenue year with strong margin discipline.
Auditor Ratification
✓ FORAuditor
Ernst & Young LLP
Tenure
27 yrs
Audit Fees
$2,501,200
Non-Audit Fees
$99,000
Ernst & Young has audited Axcelis since 1999 — approximately 27 years — which exceeds the 25-year tenure threshold that normally triggers a No vote; however, the proxy explicitly discloses that the lead audit partner rotated in February 2026 and that the next mandatory rotation is scheduled for 2031, which constitutes the specific and compelling rationale the policy requires to override the tenure trigger; non-audit fees of about $99,000 (audit-related $40,000 plus tax $51,500 plus other $7,500) represent roughly 4% of audit fees, well below the 50% threshold, so no independence concern is raised.
Overall Assessment
The 2026 Axcelis annual meeting ballot contains three proposals; the Say-on-Pay and auditor ratification proposals both pass the policy screens and receive FOR votes, but five of the eight director nominees — those with tenures that meaningfully overlap the three-year period in which Axcelis stock badly trailed the technology sector ETF (XLK) by roughly 108 percentage points — receive AGAINST votes under the TSR underperformance policy, while two newly appointed directors and one early-tenure director receive FOR votes. No stockholder proposals appear on this year's ballot.